Immunotherapy in the treatment of classic Hodgkin lymphoma

Article Properties
  • Publication Date
    2020/11/19
  • Journal
  • Indian UGC (journal)
  • Refrences
    35
  • Jozef Michalka
  • Andrea Janíková
  • Zdeněk Král
Cite
Michalka, Jozef, et al. “Immunotherapy in the Treatment of Classic Hodgkin Lymphoma”. Onkologie, vol. 14, no. 5, 2020, pp. 221-5, https://doi.org/10.36290/xon.2020.078.
Michalka, J., Janíková, A., & Král, Z. (2020). Immunotherapy in the treatment of classic Hodgkin lymphoma. Onkologie, 14(5), 221-225. https://doi.org/10.36290/xon.2020.078
Michalka J, Janíková A, Král Z. Immunotherapy in the treatment of classic Hodgkin lymphoma. Onkologie. 2020;14(5):221-5.
Refrences
Title Journal Journal Categories Citations Publication Date
Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma. Presented at the 11th International Symposium on Hodgkin Lymphoma. Abstract #0116 2018
First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi

Blood Cancer Journal
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
32 2019
10.1016/S0140-6736(15)60165-9
Five-year survival and durability results of brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma

Blood Journal
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Medicine (General)
283 2016
10.1200/JCO.2011.38.0410